Vanguard Group Inc Werewolf Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,415,530 shares of HOWL stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,415,530

Previous 1,323,781 6.93%

Holding current value

$2.25 Million

Previous $3.23 Million 7.12%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.71 - $2.95 $156,890 - $270,659	91,749 Added 6.93%	1,415,530 $3 Million
Q2 2024 Aug 13, 2024	BUY	$2.34 - $6.75 $506,455 - $1.46 Million	216,434 Added 19.55%	1,323,781 $3.23 Million
Q1 2024 May 10, 2024	BUY	$3.92 - $7.91 $916,923 - $1.85 Million	233,909 Added 26.78%	1,107,347 $7.18 Million
Q4 2023 Feb 14, 2024	BUY	$1.78 - $4.15 $579,900 - $1.35 Million	325,787 Added 59.49%	873,438 $3.37 Million
Q3 2023 Nov 14, 2023	BUY	$2.0 - $3.82 $167,474 - $319,875	83,737 Added 18.05%	547,651 $1.17 Million
Q1 2023 May 15, 2023	BUY	$1.98 - $4.3 $29,674 - $64,444	14,987 Added 3.34%	463,914 $1.21 Million
Q4 2022 Feb 10, 2023	BUY	$1.53 - $4.73 $20,916 - $64,663	13,671 Added 3.14%	448,927 $920,000
Q3 2022 Nov 14, 2022	BUY	$4.14 - $7.42 $162,234 - $290,767	39,187 Added 9.89%	435,256 $1.96 Million
Q2 2022 Aug 12, 2022	SELL	$3.43 - $5.98 $432,241 - $753,587	-126,018 Reduced 24.14%	396,069 $1.62 Million
Q1 2022 May 13, 2022	SELL	$3.71 - $12.22 $20,249 - $66,696	-5,458 Reduced 1.03%	522,087 $2.3 Million
Q4 2021 Feb 14, 2022	BUY	$11.48 - $17.65 $4.1 Million - $6.31 Million	357,280 Added 209.84%	527,545 $6.28 Million
Q3 2021 Nov 12, 2021	SELL	$13.89 - $20.31 $39,753 - $58,127	-2,862 Reduced 1.65%	170,265 $2.92 Million
Q2 2021 Aug 13, 2021	BUY	$11.6 - $17.44 $2.01 Million - $3.02 Million	173,127 New	173,127 $3.02 Million

Others Institutions Holding HOWL

# of Institutions

Shares Held

31.8M

Call Options Held

700

Put Options Held

500

View Full List

About Werewolf Therapeutics, Inc.

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $47M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

More about HOWL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Werewolf Therapeutics, Inc. Transaction History